BioXcel Therapeutics
BTAI
BTAI
34 hedge funds and large institutions have $1.19M invested in BioXcel Therapeutics in 2025 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 5 closing their positions.
Holders
34
Holders Change
+4
Holders Change %
+13.33%
% of All Funds
0.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
6
Reduced
8
Closed
5
Calls
$15K
Puts
$4K
Net Calls
+$11K
Net Calls Change
-$2K
Top Buyers
Top Sellers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$72.2K |
| 2 |
M
2
Murchinson
Toronto,
Ontario, Canada
|
$146K |
| 3 |
3
Goldman Sachs
New York
|
$0 |
| 4 |
VF
4
Virtu Financial
New York
|
$0 |
| 5 |
5
BlackRock
New York
|
$32.2K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
JPMorgan Chase & Co
New York
| $81 | 45 | -71 | -61% |
|
27
BNP Paribas Financial Markets
Paris,
France
| $80 | 44 | – | – |
|
|
NA
28
NewEdge Advisors
New Orleans,
Louisiana
| $57 | 31 | – | – |
|
29
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| $38 | 21 | – | – |
|
30
National Bank of Canada
Montreal,
Quebec, Canada
| $11 | 6 | -21 | -78% |
|
|
FDCDDQ
31
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $2 | 1 | -2 | -67% |
|
32
US Bancorp
Minneapolis,
Minnesota
| $2 | 1 | – | – |
|
|
MYIA
33
Mount Yale Investment Advisors
Denver,
Colorado
| $2 | 1 | +1 | New |
|
|
34
Goldman Sachs
New York
| – | – | -24,794 | Closed |
|
|
VF
35
Virtu Financial
New York
| – | – | -10,666 | Closed |
|
36
Barclays
London,
United Kingdom
| $0 | 8 | -1,902 | -100% |
|
37
Federated Hermes
Pittsburgh,
Pennsylvania
| – | – | -237 | Closed |
|
38
Fidelity Investments
Boston,
Massachusetts
| – | – | -11 | Closed |
|
|
FFA
39
Farther Finance Advisors
San Francisco,
California
| – | – | -5 | Closed |
|